TOPOTECAN

Brand name:

• Topotecan Accord®

Form and strength:

Please search for and view the medicine's Public Summary Document (PSD) for more information

Condition/indication:
(therapeutic use)

• Advanced metastatic ovarian cancer

Listing requested:

Please see PSD for more information

Funding program:

Please see PSD for more information

Request authority level:

Please see PSD for more information

PBAC submission type:

New listing (Minor)

Comment:

--

Submission sponsor:

Accord Healthcare

Other PBAC consideration:

--

Submission received for:

July 2020 PBAC meeting

Opportunity for consumer comment:

Open 29/04/2020 and close 10/06/2020 (see PBS Website)

PBAC meeting:

Held on 08/07/2020

PBAC outcome published:

Recommended (see PBAC Outcomes)

Notice of intent submitted:

03/08/2020

Lodgement of required documentation:

11/08/2020

Acceptance of complete documentation:

Accepted

Agreement to listing arrangements:

Commenced on 18/08/2020

Status:

Finalised

Government processes:

Commenced on 07/09/2020

Medicine listed on the PBS:

01/11/2020 (see PBS schedule)

---